Cubist Systematic Strategies, LLC Igm Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 9,908 shares of IGMS stock, worth $12,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,908

Previous 30,148 67.14%

Holding current value

$12,385

Previous $184,000 94.02%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.15 - $6.8 $23,276 - $137,632	-20,240 Reduced 67.14%	9,908 $11,000
Q4 2024 Feb 14, 2025	BUY	$6.05 - $17.83 $182,395 - $537,538	30,148 New	30,148 $184,000
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $21,483 - $37,851	3,300 New	3,300 $22,000
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $73,635 - $116,354	8,311 Added 379.67%	10,500 $96,000
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $30,076 - $56,388	2,189 New	2,189 $30,000
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $40,076 - $70,198	-2,599 Reduced 11.6%	19,801 $450,000
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $187,014 - $359,371	14,093 Added 169.65%	22,400 $404,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $337,378 - $747,412	-25,140 Reduced 75.16%	8,307 $222,000
Q4 2021 Feb 14, 2022	BUY	$27.59 - $66.39 $768,629 - $1.85 Million	27,859 Added 498.55%	33,447 $981,000
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $367,466 - $506,552	5,588 New	5,588 $367,000
Q2 2021 Aug 16, 2021	SELL	$57.98 - $96.6 $306,366 - $510,434	-5,284 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$71.56 - $121.23 $166,162 - $281,496	-2,322 Reduced 30.53%	5,284 $405,000
Q4 2020 Feb 16, 2021	BUY	$47.41 - $115.03 $162,379 - $393,977	3,425 Added 81.92%	7,606 $672,000
Q3 2020 Nov 16, 2020	BUY	$43.0 - $84.01 $179,783 - $351,245	4,181 New	4,181 $309,000
Q4 2019 Feb 14, 2020	SELL	$17.25 - $49.51 $91,528 - $262,700	-5,306 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$17.75 - $24.3 $94,181 - $128,935	5,306 New	5,306 $94,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

16.2M

Call Options Held

26.8K

Put Options Held

800

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $36.2M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Igm Biosciences, Inc. Transaction History